Djibouti vs Solomon Islands: Previously treated cases tested for RR-/MDR-TB
Djibouti
17.0%
in 2022
Solomon Islands
9.1%
in 2024
Djibouti rank
166th
Solomon Islands rank
167th
Previously treated cases tested for RR-/MDR-TB over time
- Djibouti
- Solomon Islands
How they compare
Djibouti currently reports 17.0% against 9.1% in Solomon Islands, a difference of 7.9%.
That makes Djibouti's figure about 1.9 times Solomon Islands's.
The two have swapped places 1 time across 7 shared years of data; in 2014 it was Solomon Islands ahead.
Djibouti ranks 166th and Solomon Islands ranks 167th of 180 countries.
Djibouti has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Djibouti | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.8% | 21.7% | 52.2% | Djibouti |
| 2020s | 17.0% | 0.0% | 17.0% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Djibouti or Solomon Islands?
- Djibouti, at 17.0% against 9.1% in Solomon Islands as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Djibouti and Solomon Islands?
- 7.9%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Solomon Islands?
- 7 years are reported by both, from 2014 to 2022.
- How do Djibouti and Solomon Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Djibouti ranks 166th and Solomon Islands ranks 167th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.